| 申请类型 | 申请号 | 药品名称 | 活性成分 | 活性成分中文 | 执行时间 | 持有公司 | 说明书 |
|---|---|---|---|---|---|---|---|
| BLA | 761310 | ELAHERE | MIRVETUXIMAB SORAVTANSINE-GYNX | 查看 | 2022-11-14 | IMMUNOGEN INC | 查看 |
| BLA | 761291 | TECVAYLI | TECLISTAMAB-CQYV | 查看 | 2022-10-26 | JANSSEN BIOTECH | 查看 |
| BLA | 761289 | IMJUDO | TREMELIMUMAB-ACTL | 查看 | 2022-11-01 | ASTRAZENECA AB | 查看 |
| BLA | 761289 | IMJUDO | TREMELIMUMAB-ACTL | 查看 | 2022-10-31 | ASTRAZENECA AB | 查看 |
| BLA | 761278 | LAMZEDE | VELMANASE ALFA-TYCV | 查看 | 2023-02-17 | CHIESI FARMACEUTICI SPA | 查看 |
| BLA | 761270 | IMJUDO | TREMELIMUMAB-ACTL | 查看 | 2022-11-13 | ASTRAZENECA AB | 查看 |
| BLA | 761269 | LEQEMBI | LECANEMAB-IRMB | 查看 | 2023-01-06 | EISAI INC | 查看 |
| BLA | 761268 | VEGZELMA | BEVACIZUMAB-ADCD | 查看 | 2022-09-28 | CELLTRION | 查看 |
| BLA | 761263 | LUNSUMIO | MOSUNETUZUMAB-AXGB | 查看 | 2022-12-23 | GENENTECH INC | 查看 |
| BLA | 761262 | SKYRIZI | RISANKIZUMAB-RZAA | 查看 | 2022-11-28 | ABBVIE INC | 查看 |
| BLA | 761262 | SKYRIZI | RISANKIZUMAB-RZAA | 查看 | 2022-09-27 | ABBVIE INC | 查看 |
| BLA | 761262 | SKYRIZI | RISANKIZUMAB-RZAA | 查看 | 2022-06-21 | ABBVIE INC | 查看 |
| BLA | 761261 | XENPOZYME | OLIPUDASE ALFA-RPCP | 查看 | 2022-09-01 | GENZYME CORP | 查看 |
| BLA | 761255 | IDACIO | ADALIMUMAB-AACF | 查看 | 2022-12-14 | FRESENIUS KABI USA | 查看 |
| BLA | 761244 | SPEVIGO | SPESOLIMAB-SBZO | 查看 | 2022-09-02 | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 查看 |
| BLA | 761238 | BRIUMVI | UBLITUXIMAB-XIIY | 查看 | 2022-12-28 | TG THERAPEUTICS, INC | 查看 |
| BLA | 761235 | VABYSMO | FARICIMAB-SVOA | 查看 | 2023-01-30 | GENENTECH INC | 查看 |
| BLA | 761235 | VABYSMO | FARICIMAB-SVOA | 查看 | 2022-02-01 | GENENTECH INC | 查看 |
| BLA | 761234 | OPDUALAG | NIVOLUMAB;RELATLIMAB-RMBW | 查看 | 2022-03-18 | BRISTOL MYERS SQUIBB | 查看 |
| BLA | 761231 | ALYMSYS | BEVACIZUMAB-MALY | 查看 | 2022-04-13 | AMNEAL PHARMS LLC | 查看 |